Variables | Code | Freq. (%) | Variables | Code | Value |
---|---|---|---|---|---|
Demographic information | Total Costs & reimbursement (CNY/%) | ||||
Leukemia Type | ALL | 596(77.9%) | Total Cost | Median | 244,250.1 |
AML | 111(14.5%) | IQR | 156,330.8–357,847.4 | ||
Transplantation | 58(7.6%) | Total OOP | Median | 182,860.2 | |
Hospitals | Nanfang H | 469(61.3%) | IQR | 112,324.1–266,849.7 | |
Zhujiang H | 296(38.7%) | Total Reimbursement | Median | 47,575.45 | |
Insurance Type | GZ-RBMI | 75(9.8%) | IQR | 0.00–115,375.0 | |
GD-contracted | 412(53.9%) | RR | Median | 24.16 | |
GD-uncontracted | 60(7.8%) | IQR | 0.00–39.74 | ||
Other-contracted | 38(5.0%) | ||||
Other-uncontracted | 46(6.0%) | Cost structures (CNY) | |||
OOP | 134(17.5%) | Operation/Procedure | Median | 481.59 | |
Year | 2015 | 212(27.7%) | IQR | 286.00–867.59 | |
2016 | 147(19.2%) | Simple Treatment | Median | 0.00 | |
2017 | 170(22.2%) | IQR | 0.00–0.00 | ||
2018 | 144(18.8%) | Blood Products | Median | 12,095.00 | |
2019 | 92(12.0%) | IQR | 5760.00–24,125.00 | ||
Sex | Male | 482(63.0%) | Drug | Median | 91,486.07 |
Female | 283(37.0%) | IQR | 44,721.65–152,689.1 | ||
Age | 0–5 | 419(54.8%) | |||
6–10 | 190(24.8%) | Treatment Duration (Days) | |||
11–15 | 156(20.4%) | Total Treatment Duration | Median | 526.00 | |
Region | GD-PRD | 261(34.1%) | IQR | 319.00–764.50 | |
GD-Other | 349(45.6%) | ||||
Outside GD | 155(20.3%) | Total Inpatient Days | Median | 164.00 | |
Hukou | Urban | 347(45.4%) | IQR | 126.00–213.50 | |
Rural | 418(54.6%) |